Login to Your Account

Acambis Files 'First-Ever' BLA: Arilvax Vaccine In Yellow Fever

By Kim Coghill

Monday, December 15, 2003
Acambis plc filed a biologics license application seeking approval of Arilvax as a vaccine to prevent yellow fever. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription